Bio Solution Co.,Ltd. (KOSDAQ:086820)

Market Cap	216.76B +0.2%
Revenue (ttm)	15.20B +83.7%
Net Income	273.36M
EPS	11.32
Shares Out	25.80M
PE Ratio	792.93
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	128,217
Average Volume	222,713
Open	8,730.00
Previous Close	8,730.00
Day's Range	8,350.00 - 8,870.00
52-Week Range	7,130.00 - 13,450.00
Beta	n/a
RSI	27.42
Earnings Date	May 22, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic...

• Founded: 2000
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 086820